急性胰腺炎(以下简称AP)的发病机理和临床诊治至今尚有许多问题未解决,急性出血性坏死性胰腺炎的死亡率仍很高,其治疗仍是当今国内外重要的研究课题。当前AP治疗措施的基本目的是:1.控制胰腺炎症的发展,包括抑制胰液分泌和胰酶活性;2.阻断并发症的发生;3.治疗并发症和支持疗法。前两类措施又称之为AP的特异性治疗,是基于对 Acute pancreatitis (hereinafter referred to as AP) pathogenesis and clinical diagnosis and treatment there are still many unsolved, acute hemorrhagic necrotizing pancreatitis mortality is still high, the treatment is still an important research topic at home and abroad. The basic goals of current AP treatment are: 1. Control of pancreatic inflammation, including inhibition of pancreatic secretion and pancreatic enzyme activity; 2. Blocking of complications; 3. Complications and supportive care. The first two types of measures, also known as AP-specific treatment, are based on right